SymbolGUTS
NameFRACTYL HEALTH, INC.
SectorUNDEFINED
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
AddressMassachusetts, 02421, United States
Telephone(781) 902-8800
Fax
Email
Websitehttps://www.fractyl.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001572616
Description

Fractyl Health is a leading metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Our Revita and Rejuva platform candidates are designed to target root causes of metabolic diseases and to transform metabolic disease treatment from chronic management to potentially preventing and reversing metabolic disease.

Additional info from NASDAQ:
Fractyl Health is a leading metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Our Revita and Rejuva platform candidates are designed to target root causes of metabolic diseases and to transform metabolic disease treatment from chronic management to potentially preventing and reversing metabolic disease.

2026-05-13 17:21

New Form SCHEDULE 13G/A - FRACTYL HEALTH, INC. <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001104659-26-060268 <b>Size:</b> 8 KB

Read more
2026-05-12 20:05

(30% Negative) FRACTYL HEALTH, INC. (GUTS) Reports Q2 2026 Financial Results

Read more
2026-05-11 11:00

(90% Positive) FRACTYL HEALTH, INC. (GUTS) Announces Enrollment Update for expected Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Read more
2026-05-11 11:00

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

Read more
2026-04-24 17:11

New Form DEFA14A - FRACTYL HEALTH, INC. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177245 <b>Size:</b> 3 MB

Read more
2026-04-24 17:05

New Form DEF 14A - FRACTYL HEALTH, INC. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177134 <b>Size:</b> 6 MB

Read more
2026-03-24 20:03

(30% Negative) FRACTYL HEALTH, INC. (GUTS) Reports Q1 2026 Financial Results

Read more
2026-03-24 20:01

Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Read more
2026-03-21 02:29

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Read more
2026-03-21 02:29

GUTS attributes changed: Attr: Fin_status N -> D;

Read more